XML 35 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-based Compensation
3 Months Ended
Sep. 30, 2017
Share-based Compensation  
Share-based Compensation

Note 17.  Share-based Compensation

 

At September 30, 2017, the Company had two share-based employee compensation plans (the 2011 Long-Term Incentive Plan “LTIP” and the 2014 “LTIP”).  Together these plans authorized an aggregate total of 4.5 million shares to be issued.  The plans have a total of 1.7 million shares available for future issuances.

 

The Company issues share-based compensation awards with a vesting period ranging up to 3 years and a maximum contractual term of 10 years.  The Company issues new shares of stock when stock options are exercised.  As of September 30, 2017, there was $11.3 million of total unrecognized compensation cost related to non-vested share-based compensation awards.  That cost is expected to be recognized over a weighted average period of 2.4 years.

 

Stock Options

 

The Company measures share-based compensation cost for options using the Black-Scholes option pricing model.  The following table presents the weighted average assumptions used to estimate fair values of the stock options granted during the three months ended September 30, 2017 and 2016, the estimated annual forfeiture rates used to recognize the associated compensation expense and the weighted average fair value of the options granted:

 

 

 

September 30,
2017

 

September 30,
2016

 

Risk-free interest rate

 

1.9

%

1.1

%

Expected volatility

 

57.4

%

55.6

%

Expected dividend yield

 

 

 

Forfeiture rate

 

6.5

%

6.5

%

Expected term (in years)

 

5.4 years

 

5.2 years

 

Weighted average fair value

 

$

9.06

 

$

15.33

 

 

Expected volatility is based on the historical volatility of the price of our common shares during the historical period equal to the expected term of the option.  The Company uses historical information to estimate the expected term, which represents the period of time that options granted are expected to be outstanding.  The risk-free rate for the period equal to the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of grant.  The forfeiture rate assumption is the estimated annual rate at which unvested awards are expected to be forfeited during the vesting period.  This assumption is based on our actual forfeiture rate on historical awards.  Periodically, management will assess whether it is necessary to adjust the estimated rate to reflect changes in actual forfeitures or changes in expectations.  Additionally, the expected dividend yield is equal to zero, as the Company has not historically issued and has no immediate plans to issue, a dividend.

 

A stock option roll-forward as of September 30, 2017 and changes during the three months then ended, is presented below:

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted-

 

 

 

Average

 

 

 

 

 

Average

 

Aggregate

 

Remaining

 

 

 

 

 

Exercise

 

Intrinsic

 

Contractual

 

(In thousands, except for weighted average price and life data)

 

Awards

 

Price

 

Value

 

Life (yrs.)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2017

 

1,475

 

$

18.02

 

$

12,212

 

5.7

 

Granted

 

18

 

$

17.40

 

 

 

 

 

Exercised

 

(14

)

$

6.53

 

$

150

 

 

 

Forfeited, expired or repurchased

 

(6

)

$

26.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at September 30, 2017

 

1,473

 

$

18.09

 

$

10,075

 

5.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2017

 

1,470

 

$

18.07

 

$

10,073

 

5.5

 

Exercisable at September 30, 2017

 

1,436

 

$

17.66

 

$

10,057

 

5.4

 

 

Restricted Stock

 

The Company measures restricted stock compensation costs based on the stock price at the grant date less an estimate for expected forfeitures.  The annual forfeiture rate used to calculate compensation expense was 6.5% for the three months ended September 30, 2017 and 2016.

 

A summary of restricted stock awards as of September 30, 2017 and changes during the three months then ended, is presented below:

 

(In thousands, except for weighted average price data)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

Non-vested at June 30, 2017

 

334

 

$

30.71

 

 

 

Granted

 

460

 

17.16

 

 

 

Vested

 

(116

)

35.35

 

$

2,452

 

Forfeited

 

(17

)

24.13

 

 

 

 

 

 

 

 

 

 

 

Non-vested at September 30, 2017

 

661

 

$

39.72

 

 

 

 

 

 

 

 

 

 

 

 

 

Performance-Based Shares

 

On September 22, 2017, the Company approved and granted performance-based awards to certain key executives.  The stock-settled awards will vest based on relative Total Shareholder Return (“TSR”) over a three year period.  The Company measures share-based compensation cost for TSR awards using a Monte-Carlo simulation model.  The impact of the grant was not material to the consolidated financial statements during the first quarter of Fiscal 2018.

 

Employee Stock Purchase Plan

 

In February 2003, the Company’s stockholders approved an Employee Stock Purchase Plan (“ESPP”).  Employees eligible to participate in the ESPP may purchase shares of the Company’s stock at 85% of the lower of the fair market value of the common stock on the first day of the calendar quarter, or the last day of the calendar quarter.  Under the ESPP, employees can authorize the Company to withhold up to 10% of their compensation during any quarterly offering period, subject to certain limitations.  The ESPP was implemented on April 1, 2003 and is qualified under Section 423 of the Internal Revenue Code.  The Board of Directors authorized an aggregate total of 1.1 million shares of the Company’s common stock for issuance under the ESPP.  During the three months ended September 30, 2017 and 2016, 14 thousand shares and 13 thousand shares were issued under the ESPP, respectively.  As of September 30, 2017, 557 thousand total cumulative shares have been issued under the ESPP.

 

The following table presents the allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item:

 

 

 

Three Months Ended
September 30,

 

(In thousands)

 

2017

 

2016

 

Selling, general and administrative

 

$

1,787

 

$

1,972

 

Research and development

 

151

 

173

 

Cost of sales

 

251

 

311

 

 

 

 

 

 

 

Total

 

$

2,189

 

$

2,456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

799

 

$

897